Cyclosporine Capsule, Liquid Filled
Product Images NDC 0093-9019

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclosporine (NDC 0093-9019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure of cyclosporine, showing the molecular formula C62H111N11O12 and molecular weight 1202.61. The diagram includes the sequence of amino acid residues and detailed structural elements of the molecule.*

FDA Label Image

Figure 1 (Image 2)

A bar chart titled 'ACR Responders Randomized' comparing response rates among different treatment groups, including Cyclosporine (CsA), Methotrexate (Mtx), placebo (pla), and combinations such as CsA+Mtx and pla+Mtx. The chart shows p-values above the bars indicating statistical comparisons, with response percentages on the vertical axis and treatment groups on the horizontal axis.*

FDA Label Image

1 (Image 3)

Packaging label for Cyclosporine Capsules USP Modified (Soft Gelatin Capsules) 25 mg by Teva Pharmaceuticals USA, Inc. The carton displays the product name, strength, and form, a warning about bioequivalence, prescription-only status, and a count of 30 soft gelatin capsules. The label includes manufacturer information and a barcode.*

FDA Label Image

1 (Image 4)

Packaging label for Cyclosporine Modified 25 mg soft gelatin capsules by Teva Pharmaceuticals USA, Inc. The label indicates a package size of 30 capsules and highlights that these capsules are not bioequivalent to Sandimmune. It includes the NDC 0093-9018-65 and a warning not to interchange without physician supervision.*

FDA Label Image

1 (Image 5)

Packaging label for Cyclosporine Modified 50 mg soft gelatin capsules by Teva Pharmaceuticals USA, Inc. The label indicates this is an oral prescription drug with 30 soft gelatin capsules per package. A warning states these capsules are not bioequivalent to Sandimmune and should not be used interchangeably without physician supervision.*

FDA Label Image

1 (Image 6)

Packaging label for Cyclosporine Capsules USP Modified (Soft Gelatin Capsules) 50 mg by Teva Pharmaceuticals USA, Inc. It contains 30 soft gelatin capsules. The label prominently displays the product name, strength, and a warning that these capsules are not bioequivalent to Sandimmune and should not be used interchangeably without a physician’s supervision. NDC number 0093-9019-65 is shown along with instructions for use and tamper-evident information.*

FDA Label Image

1 (Image 7)

Packaging label for Cyclosporine Modified Capsules USP Modified 100 mg, soft gelatin capsules, oral dosage form. The label shows a 30-count package by Teva Pharmaceuticals USA, Inc. It includes a warning that the capsules are not bioequivalent to Sandimmune and should not be used interchangeably without physician supervision. NDC 0093-5742-65 is visible along with instructions for alternate opening methods.*

FDA Label Image

1 (Image 8)

Label for Cyclosporine Capsules USP Modified (Soft Gelatin Capsules) 100 mg by Teva Pharmaceuticals USA, Inc. The label features dosage strength 100 mg and package size of 30 soft gelatin capsules. It includes a warning that these capsules are not bioequivalent to Sandimmune and should not be used interchangeably without physician supervision. The label includes storage and usage information, an alternate opening method illustration, and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.